Central nervous system manifestations in acute and chronic graft-versus-host disease
Nicolas Lambert,Florence Forte,Majdouline El Moussaoui,Justine Monseur,Nicole Raus,Alexey Polushin,David Michonneau,Carl Shultz,William J Hogan,Aitana Balaguer-Roselló,Sara Gil-Perotìn,Jan Brijs,Paul Chauvet,Maria Gavriilaki,Martin Carre,Adriana Octaviana Dulamea,Yves Chalandon,Urpu Salmenniemi,Andrea Duminuco,Ron Ram,Irene García-Cadenas,Gaetana Porto,Stéphanie Nguyen,Portia Smallbone,Marta González-Vicent,Jonathan D Santoro,Evelyne Willems,Frédéric Baron,Sophie Servais,Yves Beguin,Pierre Maquet,the CNS-GvHD Study Group,Nicolas Lambert,Florence Forte,Majdouline El Moussaoui,Justine Monseur,Nicole Raus,Alexey Polushin,Iaroslav Skiba,David Michonneau,Carl Shultz,William J Hogan,Aitana Balaguer-Roselló,Sara Gil-Perotín,Jan Brijs,Paul Chauvet,Maria Gavriilaki,Ioanna Sakellari,Martin Carre,Adriana Octaviana Dulamea,Alina Daniela Tanase,Yves Chalandon,Sylvain Chantepie,Andrea Duminuco,Urpu Salmenniemi,Michael Loschi,Ron Ram,Irene Garcia Cadenas,Gaetana Porto,Massimo Martino,Patrycja Mensah-Glanowska,Sara Butera,Portia Smallbone,Agnieszka Piekarska,Jeffrey K Davies,Jonathan D Santoro,Hélène Labussière-Walle,Marta Gonzalez Vicent,Stéphanie Nguyen,Maud D'Aveni,Mehdi Hamadani,Evelyne Willems,Frédéric Baron,Pierre Maquet,Yves Beguin,Sophie Servais
DOI: https://doi.org/10.1093/brain/awae340
IF: 14.5
2024-10-24
Brain
Abstract:Despite the growing evidence supporting the existence of CNS involvement in acute and chronic graft-versus-host disease (CNS-GvHD), the characteristics and course of the disease are still largely unknown. In this multicenter retrospective study, we analyzed the clinical, biological, radiological, and histopathological characteristics, as well as the clinical course of 66 patients diagnosed with possible CNS-GvHD (pCNS-GvHD), selected by predetermined diagnostic criteria. Results were then contrasted depending on whether pCNS-GvHD occurred before or after day 100 following allogeneic hematopoietic stem cell transplantation. Median time between hematopoietic stem cell transplantation and pCNS-GvHD onset was 149 days (IQ25–75 48-321), and pCNS-GvHD onset occurred before day 100 following transplantation in 44% of patients. The most frequent findings at presentation were cognitive impairment (41%), paresis (21%), altered consciousness (20%), sensory impairment (18%), and headache (15%). Clinical presentation did not significantly differ between patients with pCNS-GvHD occurring before or after day 100 following transplantation. Brain MRI found abnormalities compatible with the clinical picture in 57% of patients, while CT detected abnormalities in only 7%. Seven patients had documented spinal cord MRI abnormalities, all of them with pCNS-GvHD occurring after day 100 following transplantation. In the cerebrospinal fluid, white blood cell count was increased in 56% of the population (median 18 cells/μL). Histopathological analyses were performed on 12 specimens and were suggestive of pCNS-GvHD in 10. All compatible specimens showed parenchymal and perivascular infiltration by CD3+ and CD163+ cells. Immunosuppressive therapy was prescribed in 97% of patients, achieving complete clinical response in 27%, partial improvement in 47% and stable disease in 6%. Response to immunosuppressive therapy did not significantly differ between patients with pCNS-GvHD occurring before or after day 100 following transplantation. Clinical relapse was observed in 31% of patients who initially responded to treatment. One-year overall survival following pCNS-GvHD onset was 41%. Onset before day 100 following hematopoietic stem cell transplantation (HR [95%CI]: 2.1 [1.0-4.5]; P=0.041) and altered consciousness at initial presentation (HR [95%CI]: 3.0 [1.3-6.7]; P=0.0077) were associated with a reduced one-year overall survival probability. Among surviving patients, 61% had neurological sequelae. This study supports that immune-mediated CNS manifestations may occur following allo-HSCT. These can be associated with both acute and chronic GvHD and carry a grim prognosis. The clinical presentation as well as the radiological and biological findings appear variable.
neurosciences,clinical neurology